McBride PLC
31 October 2006
31 October 2006
McBride plc
AGM statement
McBride plc is holding its Annual General Meeting today at which the Chairman,
Lord Sheppard of Didgemere, will make the following statement:-
Trading in the early months of the current financial year has been in line with
expectations.
The household liquids businesses recently acquired from Sanmex International and
Coventry Chemicals have been integrated in line with plan and are performing as
expected.
We have recently acquired the private label business and assets of Schneider, a
Polish producer of household and personal care products for total cash
consideration of £0.8m. In the year ended 31 December 2005, the business
acquired generated revenues of approximately £2m.
For further information please contact:
McBride plc Bob Beveridge, Group Finance Director Office: 01494 607051
Mobile: 07876 593182
Miles Roberts, Chief Executive Office: 01494 607050
Financial Dynamics Andrew Dowler Office: 020 7831 3113
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.